School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Curr Top Microbiol Immunol. 2012;351:77-112. doi: 10.1007/82_2011_123.
Intradermal (ID) vaccination can offer improved immunity and simpler logistics of delivery, but its use in medicine is limited by the need for simple, reliable methods of ID delivery. ID injection by the Mantoux technique requires special training and may not reliably target skin, but is nonetheless used currently for BCG and rabies vaccination. Scarification using a bifurcated needle was extensively used for smallpox eradication, but provides variable and inefficient delivery into the skin. Recently, ID vaccination has been simplified by introduction of a simple-to-use hollow microneedle that has been approved for ID injection of influenza vaccine in Europe. Various designs of hollow microneedles have been studied preclinically and in humans. Vaccines can also be injected into skin using needle-free devices, such as jet injection, which is receiving renewed clinical attention for ID vaccination. Projectile delivery using powder and gold particles (i.e., gene gun) have also been used clinically for ID vaccination. Building off the scarification approach, a number of preclinical studies have examined solid microneedle patches for use with vaccine coated onto metal microneedles, encapsulated within dissolving microneedles or added topically to skin after microneedle pretreatment, as well as adapting tattoo guns for ID vaccination. Finally, technologies designed to increase skin permeability in combination with a vaccine patch have been studied through the use of skin abrasion, ultrasound, electroporation, chemical enhancers, and thermal ablation. The prospects for bringing ID vaccination into more widespread clinical practice are encouraging, given the large number of technologies for ID delivery under development.
皮内(ID)接种可以提供更好的免疫效果和更简单的接种后勤保障,但由于需要简单、可靠的 ID 接种方法,其在医学上的应用受到限制。曼陀(Mantoux)技术的 ID 注射需要特殊的培训,并且可能无法可靠地针对皮肤,但目前仍用于卡介苗和狂犬病疫苗接种。分叉针划痕曾广泛用于天花的根除,但提供的皮肤进入量具有可变性且效率低下。最近,通过引入一种简单易用的空心微针,ID 接种得到了简化,该微针已在欧洲获得批准用于 ID 接种流感疫苗。各种设计的空心微针已在临床前和人体中进行了研究。无针设备也可以将疫苗注射到皮肤中,例如射流注射,它正在重新受到 ID 接种的临床关注。使用粉末和金颗粒(即基因枪)的抛射投递也已在临床上用于 ID 接种。在划痕方法的基础上,许多临床前研究已经研究了用于疫苗涂覆在金属微针上的实心微针贴片,包裹在可溶解微针内,或在微针预处理后局部添加到皮肤上,以及为 ID 接种而改装纹身枪。最后,已经研究了旨在与疫苗贴片一起增加皮肤通透性的技术,这些技术通过使用皮肤擦伤、超声波、电穿孔、化学增强剂和热消融来实现。鉴于正在开发的 ID 输送技术数量众多,皮内接种在更广泛的临床实践中得到更广泛应用的前景令人鼓舞。